Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-055360

SVP & Chief Financial Officer sold 120,000 shares at $24.45 ($2,934,000)

  • SVP & Chief Financial Officer acquired 120,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2017-10-02 Option exercise +120,000 $11.34 $1,360,800 183,414 D: show line 1 in the form
Labrucherie Gil M SVP & Chief Financial Officer 2017-10-02 Sale −120,000 $24.45 $2,934,000 63,414 D: show line 2 in the form
Open-market sales · 120,000 sh · avg $24.45 · $2,934,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2017-10-02 Option exercise · Stock Option −120,000 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…